Research has shown that pancreatic cancer cells recruit and reprogram macrophages through the CCL2/CCR2 signaling pathway, leading to the subsequent release of TWEAK via the CCL5/TRAF6/NF-κB pathway. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.